72 results on '"Vandervoort PM"'
Search Results
2. Young Investigator Award Session: Clinical Science429Patient-specific numerical mitral valve modelling in secondary mitral regurgitation: clinical validity of a promising technique430Importance of the measurement of right ventricular function when exercising patients with asymptomatic severe primary mitral regurgitation431Echocardiographic deformation imaging and computer simulation for electromechanical substrate characterization in arrhythmogenic right ventricular cardiomyopathy432The right ventricle of olympic athletes: characteristics and implications for the clinical evaluation
- Author
-
Bertrand, PB., primary, Vitel, E., primary, Mast, TP., primary, D'ascenzi, F., primary, Debusschere, N., additional, Dezutter, T., additional, Mortier, P., additional, De Santis, G., additional, Vrolix, M., additional, Heyde, B., additional, Claus, P., additional, Verdonck, PR., additional, Vandervoort, PM., additional, De Beule, M., additional, Pimor, A., additional, Bouzille, G., additional, Leclercq, C., additional, Donal, E., additional, Teske, AJ., additional, Walmsley, J., additional, Van Der Heijden, JF., additional, Van Es, R., additional, Prinzen, F., additional, Delhaas, T., additional, Van Veen, T., additional, Loh, P., additional, Doevendans, P., additional, Cramer, MJ., additional, Lumens, J., additional, Pisicchio, A., additional, Caselli, S., additional, Di Paolo, FM., additional, Spataro, A., additional, and Pelliccia, A., additional
- Published
- 2016
- Full Text
- View/download PDF
3. Club 35 Poster session 2: Thursday 4 December 2014, 08:30-18:00 * Location: Poster area
- Author
-
Santos, M, Rivero, J, Mccullough, SD, Opotowsky, AR, Waxman, AB, Systrom, D, Shah, AM, Olsen, F J, Jorgensen, PG, Mogelvang, R, Jensen, JS, Fritz-Hansen, T, Bech, J, Sivertsen, J, Biering-Sorensen, T, Santoro, C, Esposito, R, Schiano Lomoriello, V, Raia, R, De Palma, D, Ippolito, R, Ierano, P, Arpino, G, De Simone, G, Galderisi, M, Cameli, M, Lisi, M, Di Tommaso, C, Solari, M, Focardi, M, Maccherini, M, Henein, M, Galderisi, M, Mondillo, S, Simova, I, Katova, T, Galderisi, M, Pauncheva, B, Vrettos, A, Dawson, D, Grigoratos, C, Papapolychroniou, C, Nihoyannopoulos, P, Danylenko, O, Kovalenko, V, Nesukay, E, Polenova, N, Titov, I, Voilliot, D, Huttin, OH, Vaugrenard, TV, Venner, CV, Sadoul, NS, Aliot, EA, Juilliere, YJ, Selton-Suty, CSS, Hamdi, I, Mahfoudhi, H, Ben Mansour, N, Dahmani, R, Lahidheb, D, Fehri, W, Haouala, H, Erken Pamukcu, H, Gerede, DM, Sorgun, M, Akbostanci, C, Turhan, S, Erol, û, Voilliot, D, Magne, JM, Dulgheru, RD, Kou, SK, Henri, CH, Caballero, LC, De Sousa, CDS, Sprynger, MS, Pierard, LP, Lancellotti, PL, Panelo, M L, Rodriguez-Fernandez, A, Escriba-Bori, S, Krol, W, Konopka, M, Burkhard, K, Jedrzejewska, I, Pokrywka, A, Klusiewicz, A, Chwalbinska, J, Dluzniewski, M, Braksator, W, Elmissiri, AM, Eid, M, Sayed, I, Awadalla, H, Schiano-Lomoriello, V, Esposito, R, Santoro, C, Lo Iudice, F, De Simone, G, Galderisi, M, Ibrahimi, P, Jashari, F, Johansson, E, Gronlund, C, Bajraktari, G, Wester, P, Henein, MY, Potluri, R, Aziz, A, Hooper, J, Mummadi, SM, Uppal, H, Asghar, O, Chandran, S, Surkova, E A, Tereshina, O V, Shchukin, U V, Rubanenko, A O, Medvedeva, E A, Hamdi, I, Mahfoudhi, H, Ben Mansour, N, Dahmani, R, Lahidheb, D, Fehri, W, Haouala, H, Krapf, L, Nguyen, V, Cimadevilla, C, Himbert, D, Brochet, E, Iung, B, Vahanian, A, Messika-Zeitoun, D, Danylenko, O, Kovalenko, V, Nesukay, E, Titov, I, Polenova, N, Van De Heyning, C M, Magne, J, Pierard, LA, Bruyere, PJ, Davin, L, De Maeyer, C, Paelinck, BP, Vrints, CJ, Lancellotti, P, Bertrand, PB, Groenendaels, Y, Vertessen, VJ, Mullens, W, Pettinari, M, Gutermann, H, Dion, RA, Verhaert, D, Vandervoort, PM, Guven, S, Sen, T, Tufekcioglu, O, Gucuk, E, Uygur, B, Kahraman, E, Valuckiene, Z, Jurkevicius, R, Pranevicius, R, Marcinkeviciene, J, Zaliaduonyte-Peksiene, D, Stoskute, N, and Zaliunas, R
- Abstract
Introduction: Among patients with unexplained dyspnea, left ventricular (LV) filling pressures (LVFP) is commonly estimated non-invasively by the E/e' ratio using Doppler echocardiography. However the accuracy of E/e' is controversial. We evaluated the correlation of E/e' ratio with invasively measured LVFP and of change in E/e' (ΔE/e') with change in LVFP. Methods: Supine and upright transthoracic echocardiography was performed in patients with unexplained dyspnea undergoing right heart catheterization. Patients with significant valvular disease and reduced LV ejection fraction (LVEF < 50%) were excluded. Pulmonary artery wedge pressure (PAWP) was used as the invasive indicator of LVFP. The mean of septal and lateral e' velocities was used for the calculation of E/e' ratio. Results: We studied 98 subjects with a mean age of 52 ± 20 years (69% of female gender). The supine E/e' and PAWP were 9.2 ± 3.2 and 12.1 ± 4.9 mmHg (range: 4-27 mmHg) respectively and were modestly correlated (r=0.38; p<0.001). With position change (supine to upright), ΔPAWP was -5.1 ± 4.3 mmHg and ΔE/e' was 0.17 ± 2.6, with no significant association between these two measures (r=0.003; p=0.98). Both E-wave (80 ± 22 to 65 ± 22 cm/s) and mean average e' (10.2 ± 3.6 to 7.3 ± 2.0 cm/s) decreased with the upright position. The ΔPAWP was correlated with ΔE-wave velocity (r=0.33; p=0.01), but not with Δe' (r=0.14; p=0.26). Conclusions: In patients with unexplained dyspnea and a preserved LVEF, E/e' is modestly, though significantly, correlated with PAWP. ΔE/e' is not correlated with ΔPAWP, partially related to the preload sensitivity of e'.
Figure Figure 1 - Supine and delta E/e' plotted - Published
- 2014
- Full Text
- View/download PDF
4. Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study.
- Author
-
Wong M, Staszewsky L, Latini R, Barlera S, Volpi A, Chiang Y, Benza RL, Gottlieb SO, Kleemann TD, Rosconi F, Vandervoort PM, Cohn JN, Val-HeFT Heart Failure Trial Investigators, Wong, Maylene, Staszewsky, Lidia, Latini, Roberto, Barlera, Simona, Volpi, Alberto, Chiang, Yann-Tong, and Benza, Raymond L
- Abstract
Objectives: The objective of the study was to evaluate the effect of an angiotensin receptor blocker on left ventricular (LV) structure and function when added to prescribed heart failure therapy.Background: The clinical benefit derived from heart failure therapy is attributed to the regression of LV remodeling.Methods: At 302 multinational sites, 5,010 patients in New York Heart Association (NYHA) classification II to IV heart failure taking angiotensin-converting enzyme inhibitor (ACEI) and/or beta-blocker (BB) were randomized into valsartan and placebo groups and followed for a mean of 22.4 months. Serial echocardiographic measurements of left ventricular internal diastolic diameter (LVIDd) and ejection fraction (EF) were recorded. Total study reproducibility calculated to 90% power at 5% significance defined detectable differences of 0.09 cm for LVIDd and 0.86% for EF.Results: Baseline LVIDd and EF for valsartan and placebo groups were similar: 3.6 +/- 0.5 versus 3.7 +/- 0.5 (cm/m(2)) and 26.6 +/- 7.3 versus 26.9 +/- 7.0 (%). Mean group changes from baseline over time were compared. Significant decrease in LVIDd and increase in EF began by four months, reached plateau by one year, and persisted to two years in valsartan compared with placebo patients, irrespective of age, gender, race, etiology, NYHA classification, and co-treatment therapy. Changes at 18 months were -0.12 +/- 0.4 versus -0.05 +/- 0.4 (cm/m(2)), p < 0.00001 for LVIDd, and +4.5 +/- 8.9 versus +3.2 +/- 8.6 (%), p < 0.00001 for EF. The exception occurred in patients taking both ACEI and BB as co-treatment, in whom the decrease in LVIDd and increase in EF were no different between valsartan and placebo groups.Conclusions: The Val-HeFT echocardiographic substudy of 5,010 patients with moderate heart failure demonstrated that valsartan therapy taken with either ACEI or BB reversed LV remodeling. [ABSTRACT FROM AUTHOR]- Published
- 2002
- Full Text
- View/download PDF
5. The Course of Atrial Functional Mitral Regurgitation: The Atrium Dictates the Path.
- Author
-
Vandervoort PM and Deferm S
- Subjects
- Humans, Heart Atria, Echocardiography, Mitral Valve Insufficiency
- Abstract
Competing Interests: Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Published
- 2024
- Full Text
- View/download PDF
6. Exercise pulmonary hypertension by the mPAP/CO slope in primary mitral regurgitation.
- Author
-
Dhont S, Stassen J, Herbots L, Hoedemakers S, Bekhuis Y, Jasaityte R, Stroobants S, Petit T, Bakelants E, Falter M, Ferreira SM, Claessen G, Nijst P, Vandervoort PM, Bertrand PB, and Verwerft J
- Subjects
- Humans, Male, Middle Aged, Female, Cardiac Output, Pulmonary Artery, Mitral Valve, Mitral Valve Insufficiency, Hypertension, Pulmonary
- Abstract
Aims: Exercise-induced pulmonary hypertension (PH), defined by a mean pulmonary arterial pressure over cardiac output (mPAP/CO) slope >3 mmHg/L/min, has important diagnostic and prognostic implications. The aim of this study is to investigate the value of the mPAP/CO slope in patients with more than moderate primary mitral regurgitation (MR) with preserved ejection fraction and no or discordant symptoms., Methods and Results: A total of 128 consecutive patients were evaluated with exercise echocardiography and cardiopulmonary testing. Clinical outcome was defined as the composite of mitral valve intervention, new-onset atrial fibrillation, cardiovascular hospitalization, and all-cause mortality. The mean age was 63 years, 61% were male, and the mean LVEF was 66 ± 6%. The mPAP/CO slope correlated with peak VO2 (r = -0.52, P < 0.001), while the peak systolic pulmonary artery pressure (sPAP) did not (r = -0.06, P = 0.584). Forty-six per cent (n = 59) had peak exercise sPAP ≥60 mmHg, and 37% (n = 47) had mPAP/CO slope >3 mmHg/L/min. Event-free survival was 55% at 1 year and 46% at 2 years, with reduced survival in patients with mPAP/CO slope >3 mmHg/L/min (hazard ratio, 4.9; 95% confidence interval, 2.9-8.2; P < 0.001). In 53 cases (41%), mPAP/CO slope and peak sPAP were discordant: patients with slope >3 mmHg/L/mmHg and sPAP <60 mmHg (n = 21) had worse outcome vs. peak sPAP ≥60 mmHg and normal slope (n = 32, log-rank P = 0.003). The mPAP/CO slope improved predictive models for outcome, incremental to resting and exercise sPAP, and peak VO2., Conclusion: Exercise PH defined by the mPAP/CO slope >3 mmHg/L/min is associated with decreased exercise capacity and a higher risk of adverse events in significant primary MR and no or discordant symptoms. The slope provides a greater prognostic value than single sPAP measures and peak VO2., Competing Interests: Conflict of interest: None declared., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
7. The Feasibility of Semi-Continuous and Multi-Frequency Thoracic Bioimpedance Measurements by a Wearable Device during Fluid Changes in Hemodialysis Patients.
- Author
-
Schoutteten MK, Lindeboom L, De Cannière H, Pieters Z, Bruckers L, Brys ADH, van der Heijden P, De Moor B, Peeters J, Van Hoof C, Groenendaal W, Kooman JP, and Vandervoort PM
- Subjects
- Humans, Feasibility Studies, Electric Impedance, Extracellular Fluid, Renal Dialysis, Wearable Electronic Devices
- Abstract
Repeated single-point measurements of thoracic bioimpedance at a single (low) frequency are strongly related to fluid changes during hemodialysis. Extension to semi-continuous measurements may provide longitudinal details in the time pattern of the bioimpedance signal, and multi-frequency measurements may add in-depth information on the distribution between intra- and extracellular fluid. This study aimed to investigate the feasibility of semi-continuous multi-frequency thoracic bioimpedance measurements by a wearable device in hemodialysis patients. Therefore, thoracic bioimpedance was recorded semi-continuously (i.e., every ten minutes) at nine frequencies (8-160 kHz) in 68 patients during two consecutive hemodialysis sessions, complemented by a single-point measurement at home in-between both sessions. On average, the resistance signals increased during both hemodialysis sessions and decreased during the interdialytic interval. The increase during dialysis was larger at 8 kHz (∆ 32.6 Ω during session 1 and ∆ 10 Ω during session 2), compared to 160 kHz (∆ 29.5 Ω during session 1 and ∆ 5.1 Ω during session 2). Whereas the resistance at 8 kHz showed a linear time pattern, the evolution of the resistance at 160 kHz was significantly different ( p < 0.0001). Measuring bioimpedance semi-continuously and w i th a multi-frequency current is a major step forward in the understanding of fluid dynamics in hemodialysis patients. This study paves the road towards remote fluid monitoring.
- Published
- 2024
- Full Text
- View/download PDF
8. Comparison of whole body versus thoracic bioimpedance in relation to ultrafiltration volume and systolic blood pressure during hemodialysis.
- Author
-
Schoutteten MK, Lindeboom L, Brys A, Lanssens D, Smeets CJP, De Cannière H, De Moor B, Peeters J, Heylen L, Van Hoof C, Groenendaal W, Kooman JP, and Vandervoort PM
- Subjects
- Humans, Blood Pressure, Reproducibility of Results, Electric Impedance, Ultrafiltration methods, Renal Dialysis
- Abstract
In contrast to whole body bioimpedance, which estimates fluid status at a single point in time, thoracic bioimpedance applied by a wearable device could enable continuous measurements. However, clinical experience with thoracic bioimpedance in patients on dialysis is limited. To test the reproducibility of whole body and thoracic bioimpedance measurements and to compare their relationship with hemodynamic changes during hemodialysis, these parameters were measured pre- and end-dialysis in 54 patients during two sessions. The resistance from both bioimpedance techniques was moderately reproducible between two dialysis sessions (intraclass correlations of pre- to end-dialysis whole body and thoracic resistance between session 1 and 2 were 0.711 [0.58-0.8] and 0.723 [0.6-0.81], respectively). There was a very high to high correlation between changes in ultrafiltration volume and changes in whole body thoracic resistance. Changes in systolic blood pressure negatively correlated to both bioimpedance techniques. Although the relationship between changes in ultrafiltration volume and changes in resistance was stronger for whole body bioimpedance, the relationship with changes in blood pressure was at least comparable for thoracic measurements. These results suggest that thoracic bioimpedance, measured by a wearable device, may serve as an interesting alternative to whole body measurements for continuous hemodynamic monitoring during hemodialysis. NEW & NOTEWORTHY We examined the role of whole body and thoracic bioimpedance in hemodynamic changes during hemodialysis. Whole body and thoracic bioimpedance signals were strongly related to ultrafiltration volume and moderately, negatively, to changes in blood pressure. This work supports the further development of a wearable device measuring thoracic bioimpedance longitudinally in patients on hemodialysis. As such, it may serve as an innovative tool for continuous hemodynamic monitoring during hemodialysis in hospital or in a home-based setting.
- Published
- 2023
- Full Text
- View/download PDF
9. When therapy becomes the source of embolism.
- Author
-
Dhont S, Gutermann H, Van Lierde J, Verbrugghe P, and Vandervoort PM
- Subjects
- Humans, Embolism, Heart Diseases, Pulmonary Embolism diagnostic imaging
- Abstract
Competing Interests: Conflict of interest: None declared.
- Published
- 2023
- Full Text
- View/download PDF
10. Arrythmia-Mediated Valvular Heart Disease.
- Author
-
Deferm S, Bertrand PB, Dhont S, von Bardeleben RS, and Vandervoort PM
- Subjects
- Humans, Aged, Heart Atria, Prognosis, Mitral Valve Insufficiency epidemiology, Mitral Valve Insufficiency etiology, Heart Valve Diseases complications, Heart Valve Diseases epidemiology, Atrial Fibrillation epidemiology
- Abstract
The aging population is rising at record pace worldwide. Along with it, a steep increase in the prevalence of atrial fibrillation and heart failure with preserved ejection fraction is to be expected. Similarly, both atrial functional mitral and tricuspid regurgitation (AFMR and AFTR) are increasingly observed in daily clinical practice. This article summarizes all current evidence regarding the epidemiology, prognosis, pathophysiology, and therapeutic options. Specific attention is addressed to discern AFMR and AFTR from their ventricular counterparts, given their different pathophysiology and therapeutic needs., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
11. Mitral Annular Dynamics in AF Versus Sinus Rhythm: Novel Insights Into the Mechanism of AFMR.
- Author
-
Deferm S, Bertrand PB, Verhaert D, Verbrugge FH, Dauw J, Thoelen K, Giesen A, Bruckers L, Rega F, Thomas JD, Levine RA, and Vandervoort PM
- Subjects
- Humans, Mitral Valve diagnostic imaging, Predictive Value of Tests, Stroke Volume, Ventricular Function, Left, Atrial Fibrillation complications, Atrial Fibrillation diagnostic imaging, Atrial Fibrillation therapy, Mitral Valve Insufficiency complications, Mitral Valve Insufficiency diagnostic imaging, Mitral Valve Insufficiency therapy
- Abstract
Objectives: This study aimed to investigate mitral annular dynamics in atrial fibrillation (AF) and after sinus rhythm restoration, and to assess the relationship between annular dynamics and mitral regurgitation (MR)., Background: AF can be associated with MR that improves after sinus rhythm restoration. Mechanisms underlying this atrial functional MR (AFMR) are ill-understood and generally attributed to left atrial remodeling., Methods: Fifty-three patients with persistent AF and normal left ventricular ejection fraction were prospectively examined by means of 3-dimensional transesophageal echocardiography before, immediately after, and 6 weeks after electric cardioversion to sinus rhythm. Annular motion was assessed during AF and in sinus rhythm with the use of 3-dimensional analysis software, and the relationship with MR severity was explored., Results: During AF and immediately after sinus rhythm restoration, the mitral annulus behaved relatively adynamically, with an overall change in annular area of 10.3% (95% CI: 8.7%-11.8%) and 12.2% (95% CI: 10.6%-13.8%), respectively. At follow-up, a significant increase in annular dynamics (19.0%; 95% CI: 17.4%-20.6%; P < 0.001) was observed, owing predominantly to an increase in presystolic contraction (P < 0.001). The effective regurgitant orifice area decreased from 0.15 cm
2 (0.10-0.23 cm2 ) during AF to 0.09 cm2 (0.05-0.12 cm2 ) at follow-up (P < 0.001) in the total cohort, and from 0.27 (0.23-0.33) to 0.16 (0.12-0.29) in the subgroup with effective regurgitant orifice area (EROA) ≥0.20 cm2 . The change in presystolic annular motion was the only independent determinant of the decrease in MR severity (P = 0.027), by optimizing annular-leaflet imbalance. Patients with more pronounced blunting of presystolic dynamics had a higher EROA (P < 0.001), because of a lower total-to-closed leaflet area ratio (P < 0.001) at each point in time. This ratio was the strongest independent determinant of AFMR severity (adjusted P = 0.003)., Conclusions: Mitral annular dynamics are impaired in AF, with blunted presystolic narrowing that contributes to AFMR. Sinus rhythm restoration allows gradual recovery of presystolic annular dynamics. Improved annular dynamics decrease AFMR severity by optimizing annular-leaflet imbalance, regardless of LA remodeling., Competing Interests: Funding Support and Author Disclosures Drs Deferm and Vandervoort are researchers for the Limburg Clinical Research Program UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk, Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital. Drs Deferm and Vandervoort are part of an Interreg project (Poly-Valve) aimed at providing tailor-made heart valve prostheses using coated biomedical polyurethane. Dr Verbrugge is supported by a Fellowship of the Belgian American Educational Foundation and by the Special Research Fund of Hasselt University (BOF19PD04). Dr Rega has been a consultant for Atricura and; LivaNova and has received research funding from Medtronic. Dr Thomas has been a consultant for and has received honoraria from Edwards, Abbott, GE, and Caption Health; and his spouse is an employee of Caption Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2022. Published by Elsevier Inc.)- Published
- 2022
- Full Text
- View/download PDF
12. Outcome and durability of mitral valve annuloplasty in atrial secondary mitral regurgitation.
- Author
-
Deferm S, Bertrand PB, Verhaert D, Dauw J, Van Keer JM, Van De Bruaene A, Herregods MC, Meuris B, Verbrugghe P, Rex S, Vandervoort PM, and Rega F
- Subjects
- Aged, Echocardiography, Female, Heart Atria surgery, Humans, Male, Middle Aged, Mitral Valve diagnostic imaging, Mitral Valve Insufficiency diagnosis, Mitral Valve Insufficiency physiopathology, Retrospective Studies, Treatment Outcome, Heart Atria diagnostic imaging, Mitral Valve surgery, Mitral Valve Annuloplasty methods, Mitral Valve Insufficiency surgery, Ventricular Function, Left physiology
- Abstract
Objectives: Atrial secondary mitral regurgitation (ASMR) is a clinically distinct form of Carpentier type I mitral regurgitation (MR), rooted in excessive atrial and mitral annular dilation in the absence of left ventricular dysfunction. Mitral valve annuloplasty (MVA) is expected to provide a more durable solution for ASMR than for ventricular secondary MR (VSMR). Yet data on MR recurrence and outcome after MVA for ASMR are scarce. This study sought to investigate surgical outcomes and repair durability in patients with ASMR, as compared with a contemporary group of patients with VSMR., Methods: Clinical and echocardiographic data from consecutive patients who underwent MVA to treat ASMR or VSMR in an academic centre were retrospectively analysed. Patient characteristics, operative outcomes, time to recurrence of ≥moderate MR and all-cause mortality were compared between patients with ASMR versus VSMR., Results: Of the 216 patients analysed, 97 had ASMR opposed to 119 with VSMR and subvalvular leaflet tethering. Patients with ASMR were typically female (68.0% vs 33.6% in VSMR, p<0.001), with a history of atrial fibrillation (76.3% vs 33.6% in VSMR, p<0.001), paralleling a larger left atrial size (p<0.033). At a median follow-up of 3.3 (IQR 1.0-7.3) years, recurrence of ≥moderate MR was significantly lower in ASMR versus VSMR (7% vs 25% at 2 years, overall log-rank p=0.001), also when accounting for all-cause death as competing risk (subdistribution HR 0.50 in ASMR, 95% CI 0.29 to 0.88, p=0.016). Moreover, ASMR was associated with better overall survival compared with VSMR (adjusted HR 0.43 95% CI 0.22 to 0.82, p=0.011), independent from baseline European System for Cardiac Operative Risk Evaluation II surgical risk score., Conclusion: Prognosis following MVA to treat ASMR is better, compared with VSMR as reflected by lower all-cause mortality and MR recurrence. Early distinction of secondary MR towards underlying ventricular versus atrial disease has important therapeutic implications., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
13. Left Atrial Mechanics Assessed Early during Hospitalization for Cryptogenic Stroke Are Associated with Occult Atrial Fibrillation: A Speckle-Tracking Strain Echocardiography Study.
- Author
-
Deferm S, Bertrand PB, Churchill TW, Sharma R, Vandervoort PM, Schwamm LH, and Yoerger Sanborn DM
- Subjects
- Echocardiography, Heart Atria diagnostic imaging, Hospitalization, Humans, Retrospective Studies, Atrial Fibrillation diagnosis, Atrial Fibrillation diagnostic imaging, Ischemic Stroke, Stroke
- Abstract
Background: Occult atrial fibrillation (AF) is an important contributor to cryptogenic stroke, yet remains difficult to unmask at presentation. This study investigated the predictive value of left atrial (LA) mechanics by strain echocardiography during stroke hospitalization for the presence of AF as detected on early 30-day monitoring and routine clinical follow-up., Methods: Left atrial mechanics were studied by strain echocardiography in a retrospective cohort of 191 patients with cryptogenic stroke and 30-day mobile cardiac outpatient telemetry poststroke to diagnose AF. After this, AF was diagnosed via routine clinical follow-up. The independent and incremental value of measures of LA size and mechanics (i.e., strain and strain rate in the reservoir, conduit, and booster pump phase) to predict AF on top of clinical characteristics was assessed., Results: Of 191 patients, 15% (n = 28) developed AF, of which 10 were observed during 30-day mobile cardiac outpatient telemetry and 18 were observed at a median follow-up of 25 (interquartile range, 10-43) months. Median time from embolic stroke to strain echocardiography was 1 day (interquartile range, 1-2 days). Left atrial mechanics were significantly worse in AF (P < .05 for all), despite largely similar baseline cardiovascular risk profile. Booster pump strain rate was the strongest predictor for AF, independent of age, LA volume index, E/e', and reservoir strain (odds ratio = 2.88 per SD increase; 95% confidence interval, 1.29-6.41; P = .010). Adding LA strain reservoir strain and booster pump function significantly enhanced a multivariate model to predict AF. Freedom from AF was significantly lower in subjects with a booster pump strain rate (at stroke presentation) worse than -0.67 sec
-1 , as derived from receiver operator curve analysis (P < .001)., Conclusions: Left atrial mechanics and particularly the LA booster pump function assessed early during hospitalization for cryptogenic stroke can identify patients at greater likelihood of future diagnosis of AF. These findings could in part relate to LA mechanical stunning after spontaneous cardioversion, which-when identified by early strain echocardiography-can inform further risk stratification and decision-making., (Copyright © 2020 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
14. Towards personalized fluid monitoring in haemodialysis patients: thoracic bioimpedance signal shows strong correlation with fluid changes, a cohort study.
- Author
-
Schoutteten MK, Vranken J, Lee S, Smeets CJP, De Cannière H, Van Hoof C, Peeters J, Groenendaal W, and Vandervoort PM
- Subjects
- Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Male, Middle Aged, Prospective Studies, Body Water, Electric Impedance, Extracellular Fluid, Intracellular Fluid, Kidney Failure, Chronic therapy, Renal Dialysis methods
- Abstract
Background: Haemodialysis (HD) patients are burdened by frequent fluid shifts which amplify their comorbidities. Bioimpedance (bioZ) is a promising technique to monitor changes in fluid status. The aim of this study is to investigate if the thoracic bioZ signal can track fluid changes during a HD session., Methods: Prevalent patients from a single centre HD unit were monitored during one to six consecutive HD sessions using a wearable multi-frequency thoracic bioZ device. Ultrafiltration volume (UFV) was determined based on the interdialytic weight gain and target dry weight set by clinicians. The correlation between the bioZ signal and UFV was analysed on population level. Additionally regression models were built and validated per dialysis session., Results: 66 patients were included, resulting in a total of 133 HD sessions. Spearman correlation between the thoracic bioZ and UFV showed a significant strong correlation of 0.755 (p < 0.01) on population level. Regression analysis per session revealed a strong relation between the bioZ value and the UFV (R
2 = 0.982). The fluid extraction prediction error of the leave-one-out cross validation was very small (56.2 ml [- 121.1-194.1 ml]) across all sessions at all frequencies., Conclusions: This study demonstrated that thoracic bioZ is strongly correlated with fluid shifts during HD over a large range of UFVs. Furthermore, leave-one-out cross validation is a step towards personalized fluid monitoring during HD and could contribute to the creation of autonomous dialysis.- Published
- 2020
- Full Text
- View/download PDF
15. LA Mechanics in Decompensated Heart Failure: Insights From Strain Echocardiography With Invasive Hemodynamics.
- Author
-
Deferm S, Martens P, Verbrugge FH, Bertrand PB, Dauw J, Verhaert D, Dupont M, Vandervoort PM, and Mullens W
- Subjects
- Aged, Cardiovascular Agents therapeutic use, Disease Progression, Female, Heart Failure drug therapy, Heart Failure mortality, Heart Failure physiopathology, Humans, Male, Middle Aged, Patient Readmission, Predictive Value of Tests, Prospective Studies, Recovery of Function, Time Factors, Treatment Outcome, Atrial Function, Left drug effects, Echocardiography, Heart Failure diagnostic imaging, Hemodynamic Monitoring, Hemodynamics drug effects
- Abstract
Objectives: The aim of this study was to assess the effect of congestion and decongestive therapy on left atrial (LA) mechanics and to determine the relationship between LA improvement after decongestive therapy and clinical outcome in immediate or chronic heart failure with reduced ejection fraction (HFrEF)., Background: LA mechanics are affected by volume/pressure overload in decompensated HFrEF., Methods: A total of 31 patients with HFrEF and immediate heart failure (age 64 ± 15 years, 74% male, left ventricular ejection fraction 20 ± 12%) underwent serial echocardiography during decongestive therapy with simultaneous hemodynamic monitoring. LA function was assessed by strain (rate) imaging. Patients were re-evaluated 6 weeks after discharge and prospectively followed up for the composite endpoint of heart failure readmission and all-cause mortality., Results: LA reservoir function was markedly reduced at baseline and improved with decongestion (peak atrial longitudinal strain from 6.4 ± 2.2% to 8.8 ± 3.0% and strain rate from 0.29 ± 0.11 s
-1 to 0.38 ± 0.13 s-1 ), independent of changes in left ventricular global longitudinal strain, LA end-diastolic volume, and mitral regurgitation severity (p < 0.001). Both measures continued to rise at 6 weeks (up to 13.4 ± 6.1% and 0.50 ± 0.19 s-1 , respectively; p < 0.001). LA pump strain rate only increased 6 weeks after discharge (-0.25 ± 0.12 s-1 to -0.55 ± 0.29 s-1 ; p < 0.010). Changes in LA mechanics correlated with changes in wedge pressure (r = -0.61; p < 0.001). Lower peak atrial longitudinal strain values after decongestion were associated with increased risk for the composite endpoint of heart failure and mortality (p < 0.019)., Conclusions: LA reservoir and booster function, while severely impaired during immediate decompensation, significantly improve during and after decongestive therapy. Poor LA reservoir function after decongestion is associated with worse outcome., (Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
16. The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy.
- Author
-
Martens P, Deferm S, Bertrand PB, Verbrugge FH, Ramaekers J, Verhaert D, Dupont M, Vandervoort PM, and Mullens W
- Subjects
- Aged, Aged, 80 and over, Atrial Fibrillation etiology, Atrial Fibrillation physiopathology, Female, Heart Atria diagnostic imaging, Heart Failure complications, Heart Failure diagnostic imaging, Heart Failure physiopathology, Humans, Male, Middle Aged, Prospective Studies, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Ventricular Function, Left, Ventricular Remodeling, Atrial Function, Left, Atrial Function, Right, Atrial Remodeling, Cardiac Resynchronization Therapy adverse effects, Heart Atria physiopathology, Heart Failure therapy
- Abstract
Objectives: This study assessed the impact of right-atrial (RA) pacing on left-atrial (LA) physiology and clinical outcome., Background: Data for the effects of RA pacing on LA synchronicity, function, and structure after cardiac resynchronization therapy (CRT) are scarce., Methods: The effect of RA pacing on LA function, morphology, and synchronicity was assessed in a prospective imaging cohort of heart failure (HF) patients in sinus rhythm with a guideline-based indication for CRT. Additionally, in a retrospective outcome cohort of consecutive HF patients undergoing CRT implantation, the relationship to RA pacing was assessed using various outcome endpoints. High versus low atrial pacing burden was defined as atrial pacing above or below 50% in both cohorts., Results: A total of 36 patients were included in the imaging cohort (68 ± 11 years of age). Six months after CRT, patients with high RA pacing burden showed less improvement in LA maximum and minimum volumes and total emptying fraction (p < 0.05). Peak atrial longitudinal strain and reservoir and booster strain rates but not conduit strain rate improved after CRT in patients with low RA pacing burden but worsened in patients with high RA pacing burden (p < 0.05 for all). A high RA pacing burden induced significant intra-atrial dyssynchrony (maximum opposing wall delay: 44 ± 13 ms vs. 97 ± 17 ms, respectively; p = 0.022). A total of 569 patients were included in the outcome cohort. After covariate adjustments were made, a high RA pacing burden was associated with reduced LV reverse remodeling (β = 8.738; 95% confidence interval [CI]: 3.101 to 14.374; p = 0.002) and new-onset or recurrent atrial fibrillation (41% vs. 22%, respectively, at a median of 31 months [range 22 to 44 months follow-up]; p < 0.001). There were no differences in time to first HF hospitalization or all-cause mortality (p = 0.185) after covariate adjustment. However, in a recurrent event analysis, HF readmissions were more common in patients exposed to a high RA pacing burden (p = 0.003)., Conclusions: RA pacing in CRT patients negatively influences LA morphology, function, and synchronicity, which is associated with worse clinical outcome, including diminished LV reverse remodeling, increased risk for new-onset or recurrent AF and heart failure readmission. Strategies reducing RA pacing burden may be warranted., (Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
17. Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.
- Author
-
Nijst P, Martens P, Dauw J, Tang WHW, Bertrand PB, Penders J, Bruckers L, Voros G, Willems R, Vandervoort PM, Dupont M, and Mullens W
- Subjects
- Aged, Female, Follow-Up Studies, Heart Failure diagnostic imaging, Humans, Male, Middle Aged, Pilot Projects, Prospective Studies, Renin-Angiotensin System drug effects, Renin-Angiotensin System physiology, Adrenergic beta-Antagonists administration & dosage, Angiotensin Receptor Antagonists administration & dosage, Cardiac Resynchronization Therapy trends, Heart Failure therapy, Mineralocorticoid Receptor Antagonists administration & dosage, Withholding Treatment trends
- Abstract
Background: The necessity of neurohumoral blockers in patients with heart failure who demonstrate normalized ejection fractions after cardiac resynchronization therapy remains unclear., Objectives: The aim of this study was to investigate the feasibility and safety of neurohumoral blocker withdrawal in patients with normalized ejection fractions after cardiac resynchronization therapy., Methods: In this prospective, open-label, randomized controlled pilot trial with a 2 × 2 factorial design, subjects were randomized to withdrawal of renin-angiotensin-aldosterone system inhibitors and/or beta-blockers versus continuation of treatment. The primary endpoint was a recurrence of negative remodeling, defined as an increase in left ventricular end-systolic volume index of >15% at 24 months. The secondary endpoint was a composite safety endpoint of all-cause mortality, heart failure-related hospitalizations, and incidence of sustained ventricular arrhythmias at 24 months., Results: Eighty subjects were consecutively enrolled and randomized among 4 groups (continuation of neurohumoral blocker therapy, n = 20; withdrawal of renin-angiotensin-aldosterone system inhibitors, n = 20; withdrawal of beta-blockers, n = 20; and withdrawal of renin-angiotensin-aldosterone system inhibitors and beta-blockers, n = 20). Of the 80 subjects, 6 (7.5%) met the primary and 4 (5%) the secondary endpoint. However, re-initiation of neurohumoral blockers occurred in 17 subjects because of hypertension or supraventricular arrhythmias., Conclusions: The incidence of the primary and secondary endpoints over a follow-up period of 2 years was low in both the control group and in the groups in which neurohumoral blockers were discontinued. However, neurohumoral blocker withdrawal was hampered by cardiac comorbidities. (Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients [STOP-CRT]; NCT02200822)., (Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
18. The Added Value of In-Hospital Tracking of the Efficacy of Decongestion Therapy and Prognostic Value of a Wearable Thoracic Impedance Sensor in Acutely Decompensated Heart Failure With Volume Overload: Prospective Cohort Study.
- Author
-
Smeets CJP, Lee S, Groenendaal W, Squillace G, Vranken J, De Cannière H, Van Hoof C, Grieten L, Mullens W, Nijst P, and Vandervoort PM
- Abstract
Background: Incomplete relief of congestion in acute decompensated heart failure (HF) is related to poor outcomes. However, congestion can be difficult to evaluate, stressing the urgent need for new objective approaches. Due to its inverse correlation with tissue hydration, continuous bioimpedance monitoring might be an effective method for serial fluid status assessments., Objective: This study aimed to determine whether in-hospital bioimpedance monitoring can be used to track fluid changes (ie, the efficacy of decongestion therapy) and the relationships between bioimpedance changes and HF hospitalization and all-cause mortality., Methods: A wearable bioimpedance monitoring device was used for thoracic impedance measurements. Thirty-six patients with signs of acute decompensated HF and volume overload were included. Changes in the resistance at 80 kHz (R
80kHz ) were analyzed, with fluid balance (fluid in/out) used as a reference. Patients were divided into two groups depending on the change in R80kHz during hospitalization: increase in R80kHz or decrease in R80kHz . Clinical outcomes in terms of HF rehospitalization and all-cause mortality were studied at 30 days and 1 year of follow-up., Results: During hospitalization, R80kHz increased for 24 patients, and decreased for 12 patients. For the total study sample, a moderate negative correlation was found between changes in fluid balance (in/out) and relative changes in R80kHz during hospitalization (rs=-0.51, P<.001). Clinical outcomes at both 30 days and 1 year of follow-up were significantly better for patients with an increase in R80kHz . At 1 year of follow-up, 88% (21/24) of patients with an increase in R80kHz were free from all-cause mortality, compared with 50% (6/12) of patients with a decrease in R80kHz (P=.01); 75% (18/24) and 25% (3/12) were free from all-cause mortality and HF hospitalization, respectively (P=.01). A decrease in R80kHz resulted in a significant hazard ratio of 4.96 (95% CI 1.82-14.37, P=.003) on the composite endpoint., Conclusions: The wearable bioimpedance device was able to track changes in fluid status during hospitalization and is a convenient method to assess the efficacy of decongestion therapy during hospitalization. Patients who do not show an improvement in thoracic impedance tend to have worse clinical outcomes, indicating the potential use of thoracic impedance as a prognostic parameter., (©Christophe J P Jp Smeets, Seulki Lee, Willemijn Groenendaal, Gabriel Squillace, Julie Vranken, Hélène De Cannière, Chris Van Hoof, Lars Grieten, Wilfried Mullens, Petra Nijst, Pieter M Vandervoort. Originally published in JMIR Cardio (http://cardio.jmir.org), 18.03.2020.)- Published
- 2020
- Full Text
- View/download PDF
19. A Vendor-Independent Mobile Health Monitoring Platform for Digital Health Studies: Development and Usability Study.
- Author
-
Vandenberk T, Storms V, Lanssens D, De Cannière H, Smeets CJ, Thijs IM, Batool T, Vanrompay Y, Vandervoort PM, and Grieten L
- Subjects
- Humans, Mobile Applications statistics & numerical data, Monitoring, Physiologic methods, Monitoring, Physiologic standards, Patient Portals, Surveys and Questionnaires, Ergonomics standards, Mobile Applications standards, Monitoring, Physiologic instrumentation
- Abstract
Background: Medical smartphone apps and mobile health devices are rapidly entering mainstream use because of the rising number of smartphone users. Consequently, a large amount of consumer-generated data is being collected. Technological advances in innovative sensory systems have enabled data connectivity and aggregation to become cornerstones in developing workable solutions for remote monitoring systems in clinical practice. However, few systems are currently available to handle such data, especially for clinical use., Objective: The aim of this study was to develop and implement the digital health research platform for mobile health (DHARMA) that combines data saved in different formats from a variety of sources into a single integrated digital platform suitable for mobile remote monitoring studies., Methods: DHARMA comprises a smartphone app, a Web-based platform, and custom middleware and has been developed to collect, store, process, and visualize data from different vendor-specific sensors. The middleware is a component-based system with independent building blocks for user authentication, study and patient administration, data handling, questionnaire management, patient files, and reporting., Results: A prototype version of the research platform has been tested and deployed in multiple clinical studies. In this study, we used the platform for the follow-up of pregnant women at risk of developing pre-eclampsia. The patients' blood pressure, weight, and activity were semi-automatically captured at home using different devices. DHARMA automatically collected and stored data from each source and enabled data processing for the end users in terms of study-specific parameters, thresholds, and visualization., Conclusions: The increasing use of mobile health apps and connected medical devices is leading to a large amount of data for collection. There has been limited investment in handling and aggregating data from different sources for use in academic and clinical research focusing on remote monitoring studies. In this study, we created a modular mobile health research platform to collect and integrate data from a variety of third-party devices in several patient populations. The functionality of the platform was demonstrated in a real-life setting among women with high-risk pregnancies., (©Thijs Vandenberk, Valerie Storms, Dorien Lanssens, Hélène De Cannière, Christophe JP Smeets, Inge M Thijs, Tooba Batool, Yves Vanrompay, Pieter M Vandervoort, Lars Grieten. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 29.10.2019.)
- Published
- 2019
- Full Text
- View/download PDF
20. Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.
- Author
-
Deferm S, Bertrand PB, Verbrugge FH, Verhaert D, Rega F, Thomas JD, and Vandervoort PM
- Subjects
- Atrial Fibrillation complications, Heart Atria diagnostic imaging, Humans, Mitral Valve diagnostic imaging, Mitral Valve Insufficiency diagnostic imaging, Mitral Valve Insufficiency etiology, Mitral Valve Insufficiency therapy, Prevalence, Prognosis, Stroke Volume, Atrial Fibrillation physiopathology, Heart Atria physiopathology, Heart Failure physiopathology, Mitral Valve physiopathology, Mitral Valve Insufficiency physiopathology
- Abstract
Unlike secondary mitral regurgitation (MR) in the setting of left ventricular (LV) disease, the occurrence of functional MR in atrial fibrillation (AF) and/or heart failure with preserved ejection fraction (HFpEF) has remained largely unspoken. LV size and systolic function are typically normal, whereas isolated mitral annular dilation and inadequate leaflet adaptation are considered mechanistic culprits. Moreover, the role of left atrial and annular dynamics in provoking MR is often underappreciated. Because of this peculiar pathophysiology, atrial functional MR benefits from a different approach compared with secondary MR. Although both AF and HFpEF-two closely related disease epidemics of the 21st century-are held responsible, current guidelines do not emphasize the need to differentiate atrial functional MR from (ventricular) secondary MR. This review summarizes the prevalence and prognostic importance of atrial functional MR, providing mechanistic insights compared with those of secondary MR and suggesting potential therapeutic targets., (Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
21. A Novel Intelligent Two-Way Communication System for Remote Heart Failure Medication Uptitration (the CardioCoach Study): Randomized Controlled Feasibility Trial.
- Author
-
Smeets CJ, Storms V, Vandervoort PM, Dreesen P, Vranken J, Houbrechts M, Goris H, Grieten L, and Dendale P
- Abstract
Background: European Society of Cardiology guidelines for the treatment of heart failure (HF) prescribe uptitration of angiotensin-converting enzyme inhibitors (ACE-I) and β-blockers to the maximum-tolerated, evidence-based dose. Although HF prognosis can drastically improve when correctly implementing these guidelines, studies have shown that they are insufficiently implemented in clinical practice., Objective: The aim of this study was to verify whether supplementing the usual care with the CardioCoach follow-up tool is feasible and safe, and whether the tool is more efficient in implementing the guideline recommendations for β-blocker and ACE-I., Methods: A total of 25 HF patients were randomly assigned to either the usual care control group (n=10) or CardioCoach intervention group (n=15), and observed for 6 months. The CardioCoach follow-up tool is a two-way communication platform with decision support algorithms for semiautomatic remote medication uptitration. Remote monitoring sensors automatically transmit patient's blood pressure, heart rate, and weight on a daily basis., Results: Patients' satisfaction and adherence for medication intake (10,018/10,825, 92.55%) and vital sign measurements (4504/4758, 94.66%) were excellent. However, the number of technical issues that arose was large, with 831 phone contacts (median 41, IQR 32-65) in total. The semiautomatic remote uptitration was safe, as there were no adverse events and no false positive uptitration proposals. Although no significant differences were found between both groups, a higher number of patients were on guideline-recommended medication dose in both groups compared with previous reports., Conclusions: The CardioCoach follow-up tool for remote uptitration is feasible and safe and was found to be efficient in facilitating information exchange between care providers, with high patient satisfaction and adherence., Trial Registration: ClinicalTrials.gov NCT03294811; https://clinicaltrials.gov/ct2/show/NCT03294811 (Archived by WebCite at http://www.webcitation.org/6xLiWVsgM)., (©Christophe JP Smeets, Valerie Storms, Pieter M Vandervoort, Pauline Dreesen, Julie Vranken, Marita Houbrechts, Hanne Goris, Lars Grieten, Paul Dendale. Originally published in JMIR Cardio (http://cardio.jmir.org), 04.04.2018.)
- Published
- 2018
- Full Text
- View/download PDF
22. Metadata Correction: Clinical Validation of Heart Rate Apps: Mixed-Methods Evaluation Study.
- Author
-
Vandenberk T, Stans J, Mortelmans C, Van Haelst R, Van Schelvergem G, Pelckmans C, Smeets CJ, Lanssens D, De Cannière H, Storms V, Thijs IM, Vaes B, and Vandervoort PM
- Abstract
[This corrects the article DOI: 10.2196/mhealth.7254.]., (©Thijs Vandenberk, Jelle Stans, Christophe Mortelmans, Ruth Van Haelst, Gertjan Van Schelvergem, Caroline Pelckmans, Christophe JP Smeets, Dorien Lanssens, Hélène De Cannière, Valerie Storms, Inge M Thijs, Bert Vaes, Pieter M Vandervoort. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 14.03.2018.)
- Published
- 2018
- Full Text
- View/download PDF
23. Bioimpedance Alerts from Cardiovascular Implantable Electronic Devices: Observational Study of Diagnostic Relevance and Clinical Outcomes.
- Author
-
Smeets CJ, Vranken J, Van der Auwera J, Verbrugge FH, Mullens W, Dupont M, Grieten L, De Cannière H, Lanssens D, Vandenberk T, Storms V, Thijs IM, and Vandervoort PM
- Subjects
- Aged, Female, Hospitalization, Humans, Male, Treatment Outcome, Cardiac Resynchronization Therapy Devices statistics & numerical data, Defibrillators, Implantable statistics & numerical data, Electric Impedance therapeutic use, Telemedicine methods
- Abstract
Background: The use of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices is expanding in the treatment of heart failure. Most of the current devices are equipped with remote monitoring functions, including bioimpedance for fluid status monitoring. The question remains whether bioimpedance measurements positively impact clinical outcome., Objective: The aim of this study was to provide a comprehensive overview of the clinical interventions taken based on remote bioimpedance monitoring alerts and their impact on clinical outcome., Methods: This is a single-center observational study of consecutive ICD and CRT patients (n=282) participating in protocol-driven remote follow-up. Bioimpedance alerts were analyzed with subsequently triggered interventions., Results: A total of 55.0% (155/282) of patients had an ICD or CRT device equipped with a remote bioimpedance algorithm. During 34 (SD 12) months of follow-up, 1751 remote monitoring alarm notifications were received (2.2 per patient-year of follow-up), comprising 2096 unique alerts (2.6 per patient-year of follow-up). Since 591 (28.2%) of all incoming alerts were bioimpedance-related, patients with an ICD or CRT including a bioimpedance algorithm had significantly more alerts (3.4 versus 1.8 alerts per patient-year of follow-up, P<.001). Bioimpedance-only alerts resulted in a phone contact in 91.0% (498/547) of cases, which triggered an actual intervention in 15.9% (87/547) of cases, since in 75.1% (411/547) of cases reenforcing heart failure education sufficed. Overall survival was lower in patients with a cardiovascular implantable electronic device with a bioimpedance algorithm; however, this difference was driven by differences in baseline characteristics (adjusted hazard ratio of 2.118, 95% CI 0.845-5.791). No significant differences between both groups were observed in terms of the number of follow-up visits in the outpatient heart failure clinic, the number of hospital admissions with a primary diagnosis of heart failure, or mean length of hospital stay., Conclusions: Bioimpedance-only alerts constituted a substantial amount of incoming alerts when turned on during remote follow-up and triggered an additional intervention in only 16% of cases since in 75% of cases, providing general heart failure education sufficed. The high frequency of heart failure education that was provided could have contributed to fewer heart failure-related hospitalizations despite significant differences in baseline characteristics., (©Christophe JP Smeets, Julie Vranken, Jo Van der Auwera, Frederik H Verbrugge, Wilfried Mullens, Matthias Dupont, Lars Grieten, Hélène De Cannière, Dorien Lanssens, Thijs Vandenberk, Valerie Storms, Inge M Thijs, Pieter M Vandervoort. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 23.11.2017.)
- Published
- 2017
- Full Text
- View/download PDF
24. Clinical Validation of Heart Rate Apps: Mixed-Methods Evaluation Study.
- Author
-
Vandenberk T, Stans J, Mortelmans C, Van Haelst R, Van Schelvergem G, Pelckmans C, Smeets CJ, Lanssens D, De Cannière H, Storms V, Thijs IM, Vaes B, and Vandervoort PM
- Abstract
Background: Photoplethysmography (PPG) is a proven way to measure heart rate (HR). This technology is already available in smartphones, which allows measuring HR only by using the smartphone. Given the widespread availability of smartphones, this creates a scalable way to enable mobile HR monitoring. An essential precondition is that these technologies are as reliable and accurate as the current clinical (gold) standards. At this moment, there is no consensus on a gold standard method for the validation of HR apps. This results in different validation processes that do not always reflect the veracious outcome of comparison., Objective: The aim of this paper was to investigate and describe the necessary elements in validating and comparing HR apps versus standard technology., Methods: The FibriCheck (Qompium) app was used in two separate prospective nonrandomized studies. In the first study, the HR of the FibriCheck app was consecutively compared with 2 different Food and Drug Administration (FDA)-cleared HR devices: the Nonin oximeter and the AliveCor Mobile ECG. In the second study, a next step in validation was performed by comparing the beat-to-beat intervals of the FibriCheck app to a synchronized ECG recording., Results: In the first study, the HR (BPM, beats per minute) of 88 random subjects consecutively measured with the 3 devices showed a correlation coefficient of .834 between FibriCheck and Nonin, .88 between FibriCheck and AliveCor, and .897 between Nonin and AliveCor. A single way analysis of variance (ANOVA; P=.61 was executed to test the hypothesis that there were no significant differences between the HRs as measured by the 3 devices. In the second study, 20,298 (ms) R-R intervals (RRI)-peak-to-peak intervals (PPI) from 229 subjects were analyzed. This resulted in a positive correlation (rs=.993, root mean square deviation [RMSE]=23.04 ms, and normalized root mean square error [NRMSE]=0.012) between the PPI from FibriCheck and the RRI from the wearable ECG. There was no significant difference (P=.92) between these intervals., Conclusions: Our findings suggest that the most suitable method for the validation of an HR app is a simultaneous measurement of the HR by the smartphone app and an ECG system, compared on the basis of beat-to-beat analysis. This approach could lead to more correct assessments of the accuracy of HR apps., (©Thijs Vandenberk, Jelle Stans, Gertjan Van Schelvergem, Caroline Pelckmans, Christophe JP Smeets, Dorien Lanssens, Hélène De Cannière, Valerie Storms, Inge M Thijs, Pieter M Vandervoort. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 25.08.2017.)
- Published
- 2017
- Full Text
- View/download PDF
25. Effective Orifice Area during Exercise in Bileaflet Mechanical Valve Prostheses.
- Author
-
Bertrand PB, Pettinari M, De Cannière H, Gutermann H, Smeets CJ, Verhaert D, Dion RA, Verdonck P, and Vandervoort PM
- Subjects
- Aortic Valve surgery, Blood Flow Velocity, Blood Pressure, Equipment Failure Analysis, Exercise Tolerance, Female, Humans, Male, Middle Aged, Mitral Valve surgery, Prosthesis Design, Aortic Valve pathology, Aortic Valve physiopathology, Echocardiography, Stress methods, Heart Valve Prosthesis, Mitral Valve pathology, Mitral Valve physiopathology
- Abstract
Background: The aims of this study were to investigate the evolution of the transprosthetic pressure gradient and effective orifice area (EOA) during dynamic bicycle exercise in bileaflet mechanical heart valves and to explore the relationship with exercise capacity., Methods: Patients with bileaflet aortic valve replacement (n = 23) and mitral valve replacement (MVR; n = 16) prospectively underwent symptom-limited supine bicycle exercise testing with Doppler echocardiography and respiratory gas analysis. Transprosthetic flow rate, peak and mean transprosthetic gradient, EOA, and systolic pulmonary artery pressure were assessed at different stages of exercise., Results: EOA at rest, midexercise, and peak exercise was 1.66 ± 0.23, 1.56 ± 0.30, and 1.61 ± 0.28 cm
2 , respectively (P = .004), in aortic valve replacement patients and 1.40 ± 0.21, 1.46 ± 0.27, and 1.48 ± 0.25 cm2 , respectively (P = .160), in MVR patients. During exercise, the mean transprosthetic gradient and the square of transprosthetic flow rate were strongly correlated (r = 0.65 [P < .001] and r = 0.84 [P < .001] for aortic valve replacement and MVR, respectively), conforming to fundamental hydraulic principles for fixed orifices. Indexed EOA at rest was correlated with exercise capacity in MVR patients only (Spearman ρ = 0.68, P = .004). In the latter group, systolic pulmonary artery pressures during exercise were strongly correlated with the peak transmitral gradient (ρ = 0.72, P < .001)., Conclusions: In bileaflet mechanical valve prostheses, there is no clinically relevant increase in EOA during dynamic exercise. Transprosthetic gradients during exercise closely adhere to the fundamental pressure-flow relationship. Indexed EOA at rest is a strong predictor of exercise capacity in MVR patients. This should be taken into account in therapeutic decision making and prosthesis selection in young and dynamic patients., (Copyright © 2016 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
26. Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications.
- Author
-
Bertrand PB, Schwammenthal E, Levine RA, and Vandervoort PM
- Subjects
- Female, Hemodynamics, Humans, Male, Exercise physiology, Exercise Test methods, Mitral Valve Insufficiency physiopathology
- Abstract
Secondary mitral valve regurgitation (MR) remains a challenging problem in the diagnostic workup and treatment of patients with heart failure. Although secondary MR is characteristically dynamic in nature and sensitive to changes in ventricular geometry and loading, current therapy is mainly focused on resting conditions. An exercise-induced increase in secondary MR, however, is associated with impaired exercise capacity and increased mortality. In an era where a multitude of percutaneous solutions are emerging for the treatment of patients with heart failure, it becomes important to address the dynamic component of secondary MR during exercise as well. A critical reappraisal of the underlying disease mechanisms, in particular the dynamic component during exercise, is of timely importance. This review summarizes the pathophysiological mechanisms involved in the dynamic deterioration of secondary MR during exercise, its functional and prognostic impact, and the way current treatment options affect the dynamic lesion and exercise hemodynamics in general., (© 2017 American Heart Association, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
27. Subclinical Myocardial Dysfunction in Asymptomatic Mitral Regurgitation: "Watchful Waiting 2.0".
- Author
-
Bertrand PB and Vandervoort PM
- Subjects
- Cardiomyopathies, Humans, Ventricular Dysfunction, Left, Mitral Valve Insufficiency, Watchful Waiting
- Published
- 2016
- Full Text
- View/download PDF
28. Mechanism of Symptomatic Improvement After Percutaneous Therapy for Secondary Mitral Regurgitation: Resting and Exercise Hemodynamics.
- Author
-
Van De Heyning CM, Bertrand PB, Debonnaire P, De Maeyer C, Vandervoort PM, Coussement P, Paelinck BP, De Bock D, Vrints CJ, and Claeys MJ
- Subjects
- Aged, Female, Humans, Male, Mitral Valve Insufficiency physiopathology, Cardiac Catheterization methods, Cardiac Surgical Procedures methods, Exercise physiology, Hemodynamics physiology, Mitral Valve surgery, Mitral Valve Insufficiency surgery, Rest physiology
- Published
- 2016
- Full Text
- View/download PDF
29. Fact or Artifact in Two-Dimensional Echocardiography: Avoiding Misdiagnosis and Missed Diagnosis.
- Author
-
Bertrand PB, Levine RA, Isselbacher EM, and Vandervoort PM
- Subjects
- Evidence-Based Medicine, Humans, Reproducibility of Results, Sensitivity and Specificity, Artifacts, Diagnostic Errors prevention & control, Echocardiography methods, Heart Diseases diagnostic imaging, Image Enhancement methods, Patient Positioning methods
- Abstract
Two-dimensional transthoracic echocardiography is the most widely used noninvasive imaging modality for the evaluation and diagnosis of cardiac pathology. However, because of the physical properties of ultrasound waves and specifics in ultrasound image reconstruction, cardiologists are often confronted with ultrasound image artifacts. It is particularly important to recognize such artifacts in order to avoid misdiagnosis of conditions ranging from aortic dissection to thrombosis and endocarditis. This overview article summarizes the most common image artifacts encountered in routine clinical practice, along with explanations of their physical mechanisms and guidance in avoiding their misinterpretation., (Copyright © 2016 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
30. Mirror artifacts in two-dimensional echocardiography: don't forget objects in the third dimension.
- Author
-
Bertrand PB, Verhaert D, and Vandervoort PM
- Subjects
- Female, Humans, Male, Reproducibility of Results, Sensitivity and Specificity, Artifacts, Echocardiography methods, Image Enhancement methods, Image Interpretation, Computer-Assisted methods, Imaging, Three-Dimensional methods, Mitral Valve diagnostic imaging
- Published
- 2015
- Full Text
- View/download PDF
31. Surgical treatment of moderate ischemic mitral regurgitation.
- Author
-
Bertrand PB, Vandervoort PM, and Dion RA
- Subjects
- Female, Humans, Male, Coronary Artery Bypass, Mitral Valve Insufficiency surgery, Myocardial Ischemia surgery
- Published
- 2015
- Full Text
- View/download PDF
32. The figure-of-eight artifact in the echocardiographic assessment of percutaneous disc occluders: impact of imaging depth and device type.
- Author
-
Bertrand PB, Grieten L, Smeets CJ, Verbrugge FH, Mullens W, Vrolix M, Rivero-Ayerza M, Verhaert D, and Vandervoort PM
- Subjects
- Equipment Failure Analysis, Phantoms, Imaging, Prosthesis Design, Reproducibility of Results, Sensitivity and Specificity, Artifacts, Echocardiography instrumentation, Echocardiography methods, Septal Occluder Device
- Abstract
Purpose: Echocardiography is increasingly important in the guidance and follow-up of percutaneous transcatheter device closures. It was recently shown that the Amplatzer left atrial appendage occluder frequently presents as a figure-of-eight artifact due to interaction of device mesh and ultrasound waves. It remains unknown whether this can be translated to other types of disc occluders. Furthermore, the morphology of this figure-of-eight artifact appears to be different in the transesophageal and transthoracic image of the same device. The aim of this study was to evaluate the echocardiographic appearance of different types of disc occluders, and to clarify differences in morphology of the figure-of-eight artifact., Methods: A mathematical model of an epitrochoid curve was used for numerical simulation of disc occluder appearance at various imaging depths. In addition, an in vitro setup was used for echocardiographic analysis of different types of disc occluders at adjustable imaging depth and position., Results: Mathematically, decreasing the imaging depth resulted in a more asymmetric figure-of-eight, i.e. with small upper part and wide lower part. In vitro results were in close agreement with the mathematical results. In addition, in vitro a figure-of-eight artifact was obtained in all different types of disc occluder devices., Conclusions: Different types of percutaneous disc occluders all present as a figure-of-eight artifact on echocardiography when imaged from a coronal imaging position. The morphology of the artifact depends on the imaging depth, with a more asymmetric figure-of-eight morphology at smaller probe-to-device distance. This clarifies the differences observed between transesophageal and transthoracic imaging., (© 2014, Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
33. Mitral valve area during exercise after restrictive mitral valve annuloplasty: importance of diastolic anterior leaflet tethering.
- Author
-
Bertrand PB, Verbrugge FH, Verhaert D, Smeets CJ, Grieten L, Mullens W, Gutermann H, Dion RA, Levine RA, and Vandervoort PM
- Subjects
- Aged, Exercise physiology, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mitral Valve Annuloplasty methods, Mitral Valve Insufficiency physiopathology, Mitral Valve Stenosis physiopathology, Ultrasonography, Exercise Test methods, Mitral Valve Annuloplasty trends, Mitral Valve Insufficiency diagnostic imaging, Mitral Valve Insufficiency surgery, Mitral Valve Stenosis diagnostic imaging, Mitral Valve Stenosis surgery
- Abstract
Background: Restrictive mitral valve annuloplasty (RMA) for secondary mitral regurgitation might cause functional mitral stenosis, yet its clinical impact and underlying pathophysiological mechanisms remain debated., Objectives: The purpose of our study was to assess the hemodynamic and clinical impact of effective orifice area (EOA) after RMA and its relationship with diastolic anterior leaflet (AL) tethering at rest and during exercise., Methods: Consecutive RMA patients (n = 39) underwent a symptom-limited supine bicycle exercise test with Doppler echocardiography and respiratory gas analysis. EOA, transmitral flow rate, mean transmitral gradient, and systolic pulmonary arterial pressure were assessed at different stages of exercise. AL opening angles were measured at rest and peak exercise. Mortality and heart failure readmission data were collected for at least 20 months after surgery., Results: EOA and AL opening angle were 1.5 ± 0.4 cm(2) and 68 ± 10°, respectively, at rest (r = 0.4; p = 0.014). EOA increased significantly to 2.0 ± 0.5 cm(2) at peak exercise (p < 0.001), showing an improved correlation with AL opening angle (r = 0.6; p < 0.001). Indexed EOA (EOAi) at peak exercise was an independent predictor of exercise capacity (maximal oxygen uptake, p = 0.004) and was independently associated with freedom from all-cause mortality or hospital admission for heart failure (p = 0.034). Patients with exercise EOAi <0.9 cm(2)/m(2) (n = 14) compared with ≥0.9 cm(2)/m(2) (n = 25) had a significantly worse outcome (p = 0.048). In multivariate analysis, AL opening angle at peak exercise (p = 0.037) was the strongest predictor of exercise EOAi., Conclusions: In RMA patients, EOA increases during exercise despite fixed annular size. Diastolic AL tethering plays a key role in this dynamic process, with increasing AL opening during exercise being associated with higher exercise EOA. EOAi at peak exercise is a strong and independent predictor of exercise capacity and is associated with clinical outcome. Our findings stress the importance of maximizing AL opening by targeting the subvalvular apparatus in future repair algorithms for secondary mitral regurgitation., (Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
34. Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.
- Author
-
Willemsen RT, van Severen E, Vandervoort PM, Grieten L, Buntinx F, Glatz JF, and Dinant GJ
- Subjects
- Adult, Aged, Aged, 80 and over, Chest Pain etiology, Cross-Sectional Studies, Emergency Service, Hospital, Fatty Acid Binding Protein 3, Female, Humans, Male, Middle Aged, Point-of-Care Systems, Predictive Value of Tests, ROC Curve, Acute Coronary Syndrome blood, Acute Coronary Syndrome diagnosis, Fatty Acid-Binding Proteins blood, Primary Health Care, Troponin T blood
- Abstract
Background: Most patients presenting chest complaints in primary care are referred to secondary care facilities, whereas only a few are diagnosed with acute coronary syndrome (ACS)., Objective: The aim is to determine the optimal cut-off value for a point-of-care heart-type fatty acid binding protein (H-FABP) test in patients presenting to the emergency department and to evaluate a possible future role of H-FABP in safely ruling out ACS in primary care., Methods: Serial plasma H-FABP (index test) and high sensitivity troponin T (hs-cTnT) (reference test) were determined in patients with any new-onset chest complaint. In a receiver operating characteristic (ROC) curve, the optimal cut-off value of H-FABP for ACS was determined. Predictive values of H-FABP for ACS were calculated., Results: For 202 consecutive patients (prevalence ACS 59%), the ROC curve based on the results of the first H-FABP was equal to the ROC curve of hs-cTnT (AUC 0.79 versus 0.80). Using a cut-off value of 4.0 ng/ml for H-FABP, sensitivity for ACS of the H-FABP (hs-cTnT) tests was 73.9% (70.6%). Negative predictive value (NPV) of H-FABP for ACS in a population representative for primary care (incidence of ACS 22%) thus could reach 90.8%., Conclusion: In patients presenting chest pain, plasma H-FABP reaches the highest diagnostic value when a cut-off value of 4 ng/ml is used. Diagnostic values of an algorithm combining point-of-care H-FABP measurement and a score of signs and symptoms should be studied in primary care, to learn if such an algorithm could safely reduce referral rate by GPs.
- Published
- 2015
- Full Text
- View/download PDF
35. Automatic mitral annulus tracking in volumetric ultrasound using non-rigid image registration.
- Author
-
De Veene H, Bertrand PB, Popovic N, Vandervoort PM, Claus P, De Beule M, and Heyde B
- Subjects
- Algorithms, Humans, Ultrasonography, Imaging, Three-Dimensional methods, Mitral Valve diagnostic imaging
- Abstract
Analysis of mitral annular dynamics plays an important role in the diagnosis and selection of optimal valve repair strategies, but remains cumbersome and time-consuming if performed manually. In this paper we propose non-rigid image registration to automatically track the annulus in 3D ultrasound images for both normal and pathological valves, and compare the performance against manual tracing. Relevant clinical properties such as annular area, circumference and excursion could be extracted reliably by the tracking algorithm. The root-mean-square error, calculated as the difference between the manually traced landmarks (18 in total) and the automatic tracking, was 1.96 ± 0.46 mm over 10 valves (5 healthy and 5 diseased) which is within the clinically acceptable error range.
- Published
- 2015
- Full Text
- View/download PDF
36. Pulmonary homograft endocarditis and aortic autograft failure after Ross procedure: a double stentless bioprosthesis approach.
- Author
-
Smeets CJ, Bertrand PB, Spadaccio C, Beran M, Verhaert D, Vandervoort PM, Gutermann H, and Dion RA
- Subjects
- Allografts, Autografts, Endocarditis, Bacterial complications, Endocarditis, Bacterial physiopathology, Hemodynamics, Humans, Intracranial Embolism etiology, Male, Prosthesis-Related Infections complications, Prosthesis-Related Infections physiopathology, Aortic Valve surgery, Bioprosthesis adverse effects, Endocarditis, Bacterial surgery, Heart Valve Prosthesis adverse effects, Prosthesis-Related Infections surgery, Pulmonary Valve surgery
- Abstract
The case is reported of a 38-year-old male patient with pulmonary homograft acute infective endocarditis and aortic root dilation that occurred 13 years after a Ross procedure for bicuspid aortic valve regurgitation. Aortic and pulmonary root replacements were performed, using a Freestyle stentless aortic root bioprosthesis in both cases, with excellent hemodynamics on postoperative echocardiography. In addition, preoperative systemic septic embolization had occurred despite an absence of left-sided endocarditis, presumably due to an intrapulmonary shunt. This case report demonstrates the feasibility of a double stentless bioprosthesis approach, and stresses the need to remain vigilant for septic embolization even in isolated right-sided endocarditis.
- Published
- 2014
37. Etiology and relevance of the figure-of-eight artifact on echocardiography after percutaneous left atrial appendage closure with the Amplatzer Cardiac Plug.
- Author
-
Bertrand PB, Grieten L, De Meester P, Verbrugge FH, Mullens W, Verhaert D, Rivero-Ayerza M, Budts W, and Vandervoort PM
- Subjects
- Female, Humans, Image Enhancement methods, Male, Reproducibility of Results, Sensitivity and Specificity, Artifacts, Atrial Appendage diagnostic imaging, Atrial Appendage surgery, Atrial Fibrillation diagnostic imaging, Atrial Fibrillation surgery, Echocardiography, Transesophageal methods, Septal Occluder Device
- Abstract
Background: The Amplatzer Cardiac Plug (ACP) device, used for percutaneous left atrial appendage closure, frequently presents as an unexplained figure-of-eight on echocardiography. The aim of this study was to clarify the figure-of-eight display of the ACP device during echocardiography and to relate this finding to device position and function., Methods: A mathematical model was developed to resemble device geometry and predict the echocardiographic appearance of the ACP device. In addition, an in vitro setup was used to validate the model. Finally, echocardiographic images of consecutive patients referred for percutaneous left atrial appendage closure (n = 24) were analyzed for the presence of a figure-of-eight display., Results: Because the ACP device resembles an epitrochoid curve, those points with tangent vector perpendicular to the ultrasound waves are emphasized, resulting in a figure-of-eight display, which can be replicated in vitro in the coronal imaging position. We found the figure-of-eight display in 100% (11 of 11) of three-dimensional periprocedural transesophageal images and in 87% (34 of 39) of postprocedural transthoracic echocardiographic images., Conclusions: The figure-of-eight display of the ACP device during echocardiography is the result of the specific epitrochoid geometry of the device mesh and its interaction with ultrasound waves. It is important to recognize the figure-of-eight as being a normal imaging artifact of a correctly deployed device in the coronal imaging position on both transesophageal and transthoracic echocardiography. In the future, this could be used during follow-up to aid clinical practitioners in assessing device position and function., (Copyright © 2014 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
38. Colour M-mode velocity propagation: a glance at intra-ventricular pressure gradients and early diastolic ventricular performance.
- Author
-
De Boeck BW, Oh JK, Vandervoort PM, Vierendeels JA, van der Aa RP, and Cramer MJ
- Subjects
- Diastole physiology, Hemorheology, Humans, Blood Flow Velocity physiology, Echocardiography, Doppler, Color, Ventricular Function, Left physiology, Ventricular Pressure physiology
- Abstract
The physiology of early-diastolic filling comprises ventricular performance and fluid dynamical principles. Elastic recoil and myocardial relaxation rate determine left ventricular early diastolic performance. The integrity of left ventricular synchrony and geometry is essential to maintain the effect of their timely action on early diastolic left ventricular filling. These factors not only are prime determinants of left ventricular pressure decay during isovolumic relaxation and immediately after mitral valve opening; they also instigate the generation of a sufficient intra-ventricular pressure gradient, which enhances efficient early diastolic left ventricular filling. Accurate assessment of diastolic (dys)function by non-invasive techniques has important therapeutic and prognostic implications but remains a challenge to the cardiologist. The evaluation of left ventricular relaxation by the standard Doppler echocardiographic parameters is hindered by their preload dependency. The colour M-mode velocity propagation of early diastolic inflow (Vp) correlates with intra-ventricular pressure gradients and is a largely preload independent index of ventricular diastolic performance. In this article, the physiologic background, utility and limitations of this promising new tool for the study of early diastolic filling are reviewed.
- Published
- 2005
- Full Text
- View/download PDF
39. Aneurysms and pseudoaneurysms of coronary arteries and saphenous vein coronary artery bypass grafts: a case report and literature review.
- Author
-
Dubois CL and Vandervoort PM
- Subjects
- Coronary Aneurysm diagnostic imaging, Coronary Aneurysm therapy, Echocardiography, Transesophageal, Electrocardiography, Humans, Incidence, Male, Middle Aged, Saphenous Vein diagnostic imaging, Coronary Aneurysm complications, Coronary Artery Bypass adverse effects, Saphenous Vein physiopathology
- Abstract
Aneurysms or pseudoaneurysms of the native coronary arteries or bypass grafts are uncommon and represent a pathology with high morbidity and mortality. We report the diagnosis of an aneurysm of a saphenous vein coronary artery bypass graft with an atypical presentation and review incidence, modes of presentation, aetiology and proposed mechanisms of formation of this and similar entities. Complications, diagnostic clues and therapeutic options are also discussed.
- Published
- 2001
- Full Text
- View/download PDF
40. Assessment of the time constant of relaxation: insights from simulations and hemodynamic measurements.
- Author
-
De Mey S, Thomas JD, Greenberg NL, Vandervoort PM, and Verdonck PR
- Subjects
- Animals, Dogs, Female, Hemodynamics physiology, Male, Monte Carlo Method, Predictive Value of Tests, Reproducibility of Results, Time Factors, Blood Pressure physiology, Computer Simulation, Diastole physiology, Models, Cardiovascular, Ventricular Function, Left physiology
- Abstract
The objective of this study was to use high-fidelity animal data and numerical simulations to gain more insight into the reliability of the estimated relaxation constant derived from left ventricular pressure decays, assuming a monoexponential model with either a fixed zero or free moving pressure asymptote. Comparison of the experimental data with the results of the simulations demonstrated a trade off between the fixed zero and the free moving asymptote approach. The latter method more closely fits the pressure curves and has the advantage of producing an extra coefficient with potential diagnostic information. On the other hand, this method suffers from larger standard errors on the estimated coefficients. The method with fixed zero asymptote produces values of the time constant of isovolumetric relaxation (tau) within a narrow confidence interval. However, if the pressure curve is actually decaying to a nonzero pressure asymptote, this method results in an inferior fit of the pressure curve and a biased estimation of tau.
- Published
- 2001
- Full Text
- View/download PDF
41. Estimation of diastolic intraventricular pressure gradients by Doppler M-mode echocardiography.
- Author
-
Greenberg NL, Vandervoort PM, Firstenberg MS, Garcia MJ, and Thomas JD
- Subjects
- Animals, Blood Pressure drug effects, Cardiotonic Agents administration & dosage, Computer Simulation, Dogs, Isoproterenol administration & dosage, Linear Models, Reproducibility of Results, Ventricular Function, Left drug effects, Blood Pressure physiology, Diastole physiology, Echocardiography methods, Models, Cardiovascular, Ventricular Function, Left physiology
- Abstract
Previous studies have shown that small intraventricular pressure gradients (IVPG) are important for efficient filling of the left ventricle (LV) and as a sensitive marker for ischemia. Unfortunately, there has previously been no way of measuring these noninvasively, severely limiting their research and clinical utility. Color Doppler M-mode (CMM) echocardiography provides a spatiotemporal velocity distribution along the inflow tract throughout diastole, which we hypothesized would allow direct estimation of IVPG by using the Euler equation. Digital CMM images, obtained simultaneously with intracardiac pressure waveforms in six dogs, were processed by numerical differentiation for the Euler equation, then integrated to estimate IVPG and the total (left atrial to left ventricular apex) pressure drop. CMM-derived estimates agreed well with invasive measurements (IVPG: y = 0.87x + 0.22, r = 0.96, P < 0.001, standard error of the estimate = 0.35 mmHg). Quantitative processing of CMM data allows accurate estimation of IVPG and tracking of changes induced by beta-adrenergic stimulation. This novel approach provides unique information on LV filling dynamics in an entirely noninvasive way that has previously not been available for assessment of diastolic filling and function.
- Published
- 2001
- Full Text
- View/download PDF
42. Mitral inertance in humans: critical factor in Doppler estimation of transvalvular pressure gradients.
- Author
-
Nakatani S, Firstenberg MS, Greenberg NL, Vandervoort PM, Smedira NG, McCarthy PM, and Thomas JD
- Subjects
- Adult, Aged, Diastole physiology, Female, Humans, Male, Middle Aged, Blood Pressure physiology, Echocardiography, Doppler methods, Mitral Valve diagnostic imaging, Mitral Valve physiology, Ventricular Pressure physiology
- Abstract
The pressure-velocity relationship across the normal mitral valve is approximated by the Bernoulli equation DeltaP = 1/2 rhoDeltav(2) + M. dv/dt, where DeltaP is the atrioventricular pressure difference, rho is blood density, v is transmitral flow velocity, and M is mitral inertance. Although M is indispensable in assessing transvalvular pressure differences from transmitral flow, this term is poorly understood. We measured intraoperative high-fidelity left atrial and ventricular pressures and simultaneous transmitral flow velocities by using transesophageal echocardiography in 100 beats (8 patients). We computed mean mitral inertance (M) by M = integral((DeltaP)-(1/2 x rho v(2))dt/integral(dv/dt)dt and we assessed the effect of the inertial term on the transmitral pressure-flow relation. ranged from 1.03 to 5.96 g/cm(2) (mean = 3.82 +/- 1.22 g/cm(2)). DeltaP calculated from the simplified Bernoulli equation (DeltaP = 1/2. rhov(2)) lagged behind (44 +/- 11 ms) and underestimated the actual peak pressures (2.3 +/- 1.1 mmHg). correlated with left ventricular systolic pressure (r = -0.68, P < 0.0001) and transmitral pressure gradients (r = 0.65, P < 0.0001). Because mitral inertance causes the velocity to lag significantly behind the actual pressure gradient, it needs to be considered when assessing diastolic filling and the pressure difference across normal mitral valves.
- Published
- 2001
- Full Text
- View/download PDF
43. Comparison of quantitative and semiquantitative methods for assessing mitral regurgitation by transesophageal echocardiography.
- Author
-
Pu M, Thomas JD, Vandervoort PM, Stewart WJ, Cosgrove DM, and Griffin BP
- Subjects
- Female, Hemodynamics physiology, Humans, Male, Middle Aged, Mitral Valve Insufficiency physiopathology, Stroke Volume physiology, Thermodilution, Echocardiography, Transesophageal methods, Mitral Valve Insufficiency diagnostic imaging
- Abstract
Semiquantitative grading of mitral regurgitation (MR) by transesophageal echocardiography (TEE) is widely used for clinical decision making. However, the relation between semiquantitative grading by biplane or multiplane TEE and quantitative measures remains undetermined. Biplane or multiplane TEE was performed in 113 patients in the operating room. MR severity was graded from 1 to 4+ by Doppler color flow mapping. MR was quantified using the thermodilution-Doppler method as mitral regurgitant stroke volume (RSV) derived from the difference between total mitral inflow measured by pulsed Doppler and forward flow measured by thermodilution. Mitral regurgitant orifice area (ROA) was calculated by RSV divided by mitral regurgitant velocity. RSV and ROA were also calculated using the proximal isovelocity surface area method. RSV and ROA significantly correlated with the semiquantitative grading either by TEE or angiogram in a nonlinear fashion, with the best fit being given by an exponential model with correlation coefficients from 0.73 to 0.87 (p <0.001). Substantially increased RSV and ROA were observed in MR grades of > or =3+. In the same grades of 3+ or 4+ MR, the largest RSV was 4 times larger than the smallest (190 to 220 vs 44 to 45 ml), and the largest ROA (1.82 to 2.0 vs 0.26 to 0.27 cm2) was sixfold larger than the smallest. Patients with 2 to 3+ MR had significantly variable RSV and ROA (range 21 to 91 ml and 0.12 to 0.65 cm2, respectively). Color flow mapping by biplane or multiplane TEE or angiography is able to categorize precisely mild (< or =2+) and severe (> or =3+) MR, but cannot accurately determine actual hemodynamic load of MR in more severe degrees of MR.
- Published
- 2001
- Full Text
- View/download PDF
44. Noninvasive estimation of transmitral pressure drop across the normal mitral valve in humans: importance of convective and inertial forces during left ventricular filling.
- Author
-
Firstenberg MS, Vandervoort PM, Greenberg NL, Smedira NG, McCarthy PM, Garcia MJ, and Thomas JD
- Subjects
- Aged, Female, Hemodynamics, Humans, Image Processing, Computer-Assisted, Male, Middle Aged, Regression Analysis, Mitral Valve physiology, Mitral Valve Insufficiency diagnostic imaging, Mitral Valve Insufficiency physiopathology, Ultrasonography, Doppler, Color, Ventricular Function, Left, Ventricular Pressure
- Abstract
Objectives: We hypothesized that color M-mode (CMM) images could be used to solve the Euler equation, yielding regional pressure gradients along the scanline, which could then be integrated to yield the unsteady Bernoulli equation and estimate noninvasively both the convective and inertial components of the transmitral pressure difference., Background: Pulsed and continuous wave Doppler velocity measurements are routinely used clinically to assess severity of stenotic and regurgitant valves. However, only the convective component of the pressure gradient is measured, thereby neglecting the contribution of inertial forces, which may be significant, particularly for nonstenotic valves. Color M-mode provides a spatiotemporal representation of flow across the mitral valve., Methods: In eight patients undergoing coronary artery bypass grafting, high-fidelity left atrial and ventricular pressure measurements were obtained synchronously with transmitral CMM digital recordings. The instantaneous diastolic transmitral pressure difference was computed from the M-mode spatiotemporal velocity distribution using the unsteady flow form of the Bernoulli equation and was compared to the catheter measurements., Results: From 56 beats in 16 hemodynamic stages, inclusion of the inertial term ([deltapI]max = 1.78+/-1.30 mm Hg) in the noninvasive pressure difference calculation significantly increased the temporal correlation with catheter-based measurement (r = 0.35+/-0.24 vs. 0.81+/-0.15, p< 0.0001). It also allowed an accurate approximation of the peak pressure difference ([deltapc+I]max = 0.95 [delta(p)cathh]max + 0.24, r = 0.96, p<0.001, error = 0.08+/-0.54 mm Hg)., Conclusions: Inertial forces are significant components of the maximal pressure drop across the normal mitral valve. These can be accurately estimated noninvasively using CMM recordings of transmitral flow, which should improve the understanding of diastolic filling and function of the heart.
- Published
- 2000
- Full Text
- View/download PDF
45. The value of assessing pulmonary venous flow velocity for predicting severity of mitral regurgitation: A quantitative assessment integrating left ventricular function.
- Author
-
Pu M, Griffin BP, Vandervoort PM, Stewart WJ, Fan X, Cosgrove DM, and Thomas JD
- Subjects
- Aged, Blood Flow Velocity, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Sensitivity and Specificity, Severity of Illness Index, Systole physiology, Thermodilution, Echocardiography, Doppler, Echocardiography, Transesophageal, Mitral Valve Insufficiency diagnostic imaging, Pulmonary Veins diagnostic imaging, Pulmonary Veins physiopathology, Ventricular Dysfunction, Left diagnostic imaging
- Abstract
Although alteration in pulmonary venous flow has been reported to relate to mitral regurgitant severity, it is also known to vary with left ventricular (LV) systolic and diastolic dysfunction. There are few data relating pulmonary venous flow to quantitative indexes of mitral regurgitation (MR). The object of this study was to assess quantitatively the accuracy of pulmonary venous flow for predicting MR severity by using transesophageal echocardiographic measurement in patients with variable LV dysfunction. This study consisted of 73 patients undergoing heart surgery with mild to severe MR. Regurgitant orifice area (ROA), regurgitant stroke volume (RSV), and regurgitant fraction (RF) were obtained by quantitative transesophageal echocardiography and proximal isovelocity surface area. Both left and right upper pulmonary venous flow velocities were recorded and their patterns classified by the ratio of systolic to diastolic velocity: normal (>/=1), blunted (<1), and systolic reversal (<0). Twenty-three percent of patients had discordant patterns between the left and right veins. When the most abnormal patterns either in the left or right vein were used for analysis, the ratio of peak systolic to diastolic flow velocity was negatively correlated with ROA (r = -0.74, P <.001), RSV (r = -0.70, P <.001), and RF (r = -0.66, P <.001) calculated by the Doppler thermodilution method; values were r = -0.70, r = -0.67, and r = -0.57, respectively (all P <.001), for indexes calculated by the proximal isovelocity surface area method. The sensitivity, specificity, and predictive values of the reversed pulmonary venous flow pattern for detecting a large ROA (>0.3 cm(2)) were 69%, 98%, and 97%, respectively. The sensitivity, specificity, and predictive values of the normal pulmonary venous flow pattern for detecting a small ROA (<0.3 cm(2)) were 60%, 96%, and 94%, respectively. However, the blunted pattern had low sensitivity (22%), specificity (61%), and predictive values (30%) for detecting ROA of greater than 0.3 cm(2) with significant overlap with the reversed and normal patterns. Among patients with the blunted pattern, the correlation between the systolic to diastolic velocity ratio was worse in those with LV dysfunction (ejection fraction <50%, r = 0.23, P >.05) than in those with normal LV function (r = -0.57, P <.05). Stepwise linear regression analysis showed that the peak systolic to diastolic velocity ratio was independently correlated with RF (P <.001) and effective stroke volume (P <.01), with a multiple correlation coefficient of 0.71 (P <.001). In conclusion, reversed pulmonary venous flow in systole is a highly specific and reliable marker of moderately severe or severe MR with an ROA greater than 0.3 cm(2), whereas the normal pattern accurately predicts mild to moderate MR. Blunted pulmonary venous flow can be seen in all grades of MR with low predictive value for severity of MR, especially in the presence of LV dysfunction. The blunted pulmonary venous flow pattern must therefore be interpreted cautiously in clinical practice as a marker for severity of MR.
- Published
- 1999
- Full Text
- View/download PDF
46. Noninvasive assessment of left atrial maximum dP/dt by a combination of transmitral and pulmonary venous flow.
- Author
-
Nakatani S, Garcia MJ, Firstenberg MS, Rodriguez L, Grimm RA, Greenberg NL, McCarthy PM, Vandervoort PM, and Thomas JD
- Subjects
- Adult, Aged, Cardiac Surgical Procedures statistics & numerical data, Echocardiography, Doppler methods, Echocardiography, Doppler statistics & numerical data, Female, Hemodynamics, Humans, Linear Models, Male, Middle Aged, Mitral Valve diagnostic imaging, Models, Cardiovascular, Monitoring, Intraoperative statistics & numerical data, Pulmonary Veins diagnostic imaging, Systole physiology, Atrial Function, Left physiology, Mitral Valve physiology, Pulmonary Veins physiology
- Abstract
Objectives: The study assessed whether hemodynamic parameters of left atrial (LA) systolic function could be estimated noninvasively using Doppler echocardiography., Background: Left atrial systolic function is an important aspect of cardiac function. Doppler echocardiography can measure changes in LA volume, but has not been shown to relate to hemodynamic parameters such as the maximal value of the first derivative of the pressure (LA dP/dt(max))., Methods: Eighteen patients in sinus rhythm were studied immediately before and after open heart surgery using simultaneous LA pressure measurements and intraoperative transesophageal echocardiography. Left atrial pressure was measured with a micromanometer catheter, and LA dP/dt(max) during atrial contraction was obtained. Transmitral and pulmonary venous flow were recorded by pulsed Doppler echocardiography. Peak velocity, and mean acceleration and deceleration, and the time-velocity integral of each flow during atrial contraction was measured. The initial eight patients served as the study group to derive a multilinear regression equation to estimate LA dP/dt(max) from Doppler parameters, and the latter 10 patients served as the test group to validate the equation. A previously validated numeric model was used to confirm these results., Results: In the study group, LA dP/dt(max) showed a linear relation with LA pressure before atrial contraction (r = 0.80, p < 0.005), confirming the presence of the Frank-Starling mechanism in the LA. Among transmitral flow parameters, mean acceleration showed the strongest correlation with LA dP/dt(max) (r = 0.78, p < 0.001). Among pulmonary venous flow parameters, no single parameter was sufficient to estimate LA dP/dt(max) with an r2 > 0.30. By stepwise and multiple linear regression analysis, LA dP/dt(max) was best described as follows: LA dP/dt(max) = 0.1 M-AC +/- 1.8 P-V - 4.1; r = 0.88, p < 0.0001, where M-AC is the mean acceleration of transmitral flow and P-V is the peak velocity of pulmonary venous flow during atrial contraction. This equation was tested in the latter 10 patients of the test group. Predicted and measured LA dP/dt(max) correlated well (r = 0.90, p < 0.0001). Numerical simulation verified that this relationship held across a wide range of atrial elastance, ventricular relaxation and systolic function, with LA dP/dt(max) predicted by the above equation with r = 0.94., Conclusions: A combination of transmitral and pulmonary venous flow parameters can provide a hemodynamic assessment of LA systolic function.
- Published
- 1999
- Full Text
- View/download PDF
47. Application of color Doppler flow mapping to calculate orifice area of St Jude mitral valve.
- Author
-
Leung DY, Wong J, Rodriguez L, Pu M, Vandervoort PM, and Thomas JD
- Subjects
- Adult, Aged, Cardiac Output, Female, Humans, Male, Middle Aged, Echocardiography, Doppler, Color, Heart Valve Prosthesis Implantation, Mitral Valve diagnostic imaging
- Abstract
Background: The effective orifice area (EOA) of a prosthetic valve is superior to transvalvular gradients as a measure of valve function, but measurement of mitral prosthesis EOA has not been reliable., Methods and Results: In vitro flow across St Jude valves was calculated by hemispheric proximal isovelocity surface area (PISA) and segment-of-spheroid (SOS) methods. For steady and pulsatile conditions, PISA and SOS flows correlated with true flow, but SOS and not PISA underestimated flow. These principles were then used intraoperatively to calculate cardiac output and EOA of newly implanted St Jude mitral valves in 36 patients. Cardiac output by PISA agreed closely with thermodilution (r=0.91, Delta=-0.05+/-0.55 L/min), but SOS underestimated it (r=0.82, Delta=-1.33+/-0.73 L/min). Doppler EOAs correlated with Gorlin equation estimates (r=0.75 for PISA and r=0.68 for SOS, P<0.001) but were smaller than corresponding in vitro EOA estimates., Conclusions: Proximal flow convergence methods can calculate forward flow and estimate EOA of St Jude mitral valves, which may improve noninvasive assessment of prosthetic mitral valve obstruction.
- Published
- 1998
- Full Text
- View/download PDF
48. Left ventricular diastolic filling with an implantable ventricular assist device: beat to beat variability with overall improvement.
- Author
-
Nakatani S, Thomas JD, Vandervoort PM, Zhou J, Greenberg NL, Savage RM, and McCarthy PM
- Subjects
- Adult, Cardiomyopathy, Dilated complications, Coronary Vessels physiology, Echocardiography, Doppler, Echocardiography, Transesophageal, Female, Heart Failure etiology, Hemodynamics, Humans, Male, Middle Aged, Myocardial Ischemia complications, Regional Blood Flow, Heart Failure therapy, Heart-Assist Devices, Ventricular Function, Left
- Abstract
Objectives: We studied the effects of left ventricular (LV) unloading by an implantable ventricular assist device on LV diastolic filling., Background: Although many investigators have reported reliable systemic and peripheral circulatory support with implantable LV assist devices, little is known about their effect on cardiac performance., Methods: Peak velocities of early diastolic filling, late diastolic filling, late to early filling ratio, deceleration time of early filling, diastolic filling period and atrial filling fraction were measured by intraoperative transesophageal Doppler echocardiography before and after insertion of an LV assist device in eight patients. A numerical model was developed to simulate this situation., Results: Before device insertion, all patients showed either a restrictive or a monophasic transmitral flow pattern. After device insertion, transmitral flow showed rapid beat to beat variation in each patient, from abnormal relaxation to restrictive patterns. However, when the average values obtained from 10 consecutive beats were considered, overall filling was significantly normalized from baseline, with early filling velocity falling from 87 +/- 31 to 64 +/- 26 cm/s (p < 0.01) and late filling velocity rising from 8 +/- 11 to 32 +/- 23 cm/s (p < 0.05), resulting in an increase in the late to early filling ratio from 0.13 +/- 0.18 to 0.59 +/- 0.38 (p < 0.01) and a rise in the atrial filling fraction from 8 +/- 10% to 26 +/- 17% (p < 0.01). The deceleration time (from 112 +/- 40 to 160 +/- 44 ms, p < 0.05) and the filling period corrected by the RR interval (from 39 +/- 8% to 54 +/- 10%, p < 0.005) were also significantly prolonged. In the computer model, asynchronous LV assistance produced significant beat to beat variation in filling indexes, but overall a normalization of deceleration time as well as other variables., Conclusions: With LV assistance, transmitral flow showed rapidly varying patterns beat by beat in each patient, but overall diastolic filling tended to normalize with an increase of atrial contribution to the filling. Because of the variable nature of the transmitral flow pattern with the assist device, the timing of the device cycle must be considered when inferring diastolic function from transmitral flow pattern.
- Published
- 1997
- Full Text
- View/download PDF
49. Physical and physiological determinants of pulmonary venous flow: numerical analysis.
- Author
-
Thomas JD, Zhou J, Greenberg N, Bibawy G, McCarthy PM, and Vandervoort PM
- Subjects
- Animals, Blood Pressure, Diastole, Hemodynamics, Humans, Models, Biological, Systole, Ventricular Function, Pulmonary Circulation, Pulmonary Veins physiology
- Abstract
To study the physical and physiological determinants of transmitral and pulmonary venous flow, a lumped-parameter model of the cardiovascular system has been created, modeling the instantaneous pressure, volume, and influx/efflux of the pulmonary veins, left atrium and ventricle, systemic arteries and veins. right atrium and ventricle, and pulmonary arteries. Initial validation has been obtained by direct comparison with transesophageal echocardiographic recordings of mitral and pulmonary venous velocity for the following clinical situations: normal diastolic function, delayed ventricular relaxation, restrictive filling due to severe systolic dysfunction, severe mitral regurgitation before and after valve repair surgery, and premature atrial contraction occurring during ventricular systole. Sensitivity analysis has been performed with a Jacobian matrix, representing the proportional change in a group of output indexes (yi) in response to isolated changes in input parameters (xj), [(delta yi/yi)/ ([delta xj/xj)], demonstrating the complementary nature of mitral and pulmonary venous A-wave velocity for predicting ventricular stiffness and atrial systolic function. This unified numerical-experimental programming environment should facilitate model refinement and physiological data exploration, in particular guiding more accurate interpretations of Doppler echocardiographic data.
- Published
- 1997
- Full Text
- View/download PDF
50. Noninvasive assessment of the ventricular relaxation time constant (tau) in humans by Doppler echocardiography.
- Author
-
Scalia GM, Greenberg NL, McCarthy PM, Thomas JD, and Vandervoort PM
- Subjects
- Blood Pressure, Heart Ventricles diagnostic imaging, Humans, Linear Models, Mathematics, Models, Cardiovascular, Time, Ventricular Function, Left physiology, Ventricular Pressure, Diastole physiology, Echocardiography, Doppler, Ventricular Function
- Abstract
Background: The time constant of ventricular relaxation (tau) is a quantitative measure of diastolic performance requiring intraventricular pressure recording. This study validates in humans an equation relating tau to left ventricular pressure at peak -dP/dt (P0), pressure at mitral valve opening (PMV), and isovolumic relaxation time (IVRTinv). The clinically obtainable parameters peak systolic blood pressure (Ps), mean left atrial pressure (PLA), and Doppler-derived IVRT (IVRTDopp) are then substituted into this equation to obtain tau Dopp noninvasively., Methods and Results: High-fidelity left atrial and left ventricular pressure recordings with simultaneous Doppler by transesophageal echocardiography were obtained from 11 patients during cardiac surgery. Direct curve fitting to the left ventricular pressure trace by Levenberg-Marquardt regression assuming a zero asymptote generated tau LM, the "gold standard" against which tau calc (IVRT inv/[ln(P0)-ln(PMV)]) and tau Dopp [IVRTDopp/[ln(Ps)-ln(PLA)]] were compared. For 123 cycles analyzed in 18 hemodynamic states, mean tau LM was 53.8 +/- 12.9 ms. tau calc (51.5 +/- 11 ms) correlated closely with this standard (r = .87, SEE = 5.5 ms). Noninvasive tau Dopp (43.8 +/- 11 ms) underestimated tau LM but exhibited close linear correlation (n = 88, r = .75, SEE = 7.5 ms). Substituting PLA = 10 mm Hg into the equation yielded tau 10 (48.7 +/- 15 ms), which also closely correlated with the standard (r = .62, SEE = 11.6 ms)., Conclusions: The previously obtained analytical expression relating IVRT, invasive pressures, and tau is valid in humans. Furthermore, a more clinically obtainable, noninvasive method of obtaining tau also closely predicts this important measure of diastolic function.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.